Phase I study

The first stage of the TrueNTH Exercise and Diet project – Phase I – took place in 2015. The team worked with men to understand the risks they were exposed to as a result of being diagnosed with prostate cancer and the further risks they encountered as a result of the treatment they received.

Widely used treatments such as hormone therapy not only have side effects such as hot flushes, fatigue and anxiety, but also put men at a substantive risk of cardiovascular problems, such as stroke and heart disease. This is because the hormones used for treatment affect how fats in the diet are metabolised and stored.

For more information about this read the section on ‘Looking after your health after treatment for prostate cancer’

The phase I study also looked at characterising strength and fitness and then working out what advice we should be giving to men with a diagnosis of prostate cancer in order to help reduce these risks to their health.

Phase II study

phamacy

This next part of the project – Phase II – follows on from the work and the findings of the phase I study. Just over 120 men have been recruited to the study. They have all been assessed at baseline (entry into the study) for cardiac fitness and lower and upper body strength. Each participant has then been given advice in the form of a personalised prescription and a book containing advice and resources – the ‘Man-ual’. The project team trained nine pharmacies in the Portsmouth area and are working closely with them to support the men through the study.

Each participant has also been given a DVD with further information and advice. The DVD can also be accessed here:

TrueNTH Exercise and Diet information and advice

How will we know if the TrueNTH Exercise and Diet project is successful?

The project will be deemed a success if we can do the following:

  • Raise awareness of prostate cancer and the fact that because the majority of men survive the disease, they often have to live with the consequences of both the cancer and it’s treatment
  • Demonstrate what the project has achieved and how it has done this
  • Provide evidence of impact on the lives of men with prostate cancer and their families
  • Disseminate the results of the project widely
  • Inform the NHS to adopt new models of care that show marked improvements in outcomes for men with prostate cancer